Nutrix
Nutrix is a Swiss health-tech startup that leverages AI and wearables combined with human care to offer scalable and cost-effective personalized at-home monitoring. Their platform targets the prevention and management of chronic diseases such as diabetes, obesity, and cardiovascular health, as well as stress and burnout. The company's flagship product, gSense, integrates AI analysis with human medical teams, connecting smart health trackers and lab tests for real-time data. Nutrix's cortiSense technology is an award-winning, patent-pending sensor for home use that measures cortisol levels in saliva for stress management. The company has a significant global presence, operating in multiple countries and expanding its reach. They have achieved notable traction with over 100k users contracted for 2025 and an 82% quarter-over-quarter growth in 2024.
Nutrix
Nutrix is a Swiss health-tech startup that leverages AI and wearables combined with human care to offer scalable and cost-effective personalized at-home monitoring. Their platform targets the prevention and management of chronic diseases such as diabetes, obesity, and cardiovascular health, as well as stress and burnout. The company's flagship product, gSense, integrates AI analysis with human medical teams, connecting smart health trackers and lab tests for real-time data. Nutrix's cortiSense technology is an award-winning, patent-pending sensor for home use that measures cortisol levels in saliva for stress management. The company has a significant global presence, operating in multiple countries and expanding its reach. They have achieved notable traction with over 100k users contracted for 2025 and an 82% quarter-over-quarter growth in 2024.
TL;DR
Founded: 2020 (Switzerland)
Headcount: 27
Focus: AI-powered at-home monitoring for chronic disease prevention & stress management
Flagship products: gSense platform; cortiSense cortisol saliva sensor
Funding to date: $3.52M–$4M reported
Company Overview
Problem Domain
Prevention and management of chronic diseases (diabetes, obesity, cardiovascular health) and stress/burnout through remote monitoring.
Founded
2020
Industry
Health‑tech / Digital health
Funding Track Record
Seed round recorded on Jul 1, 2024 (per company financial records)
$2,500,000
Previously unannounced $2.5M seed round reported alongside other seed/early funding, contributing to reported ~$4M total
Investor Signal
“Includes strategic institutional backers (Mayo Clinic) and early‑stage investors such as Simpact Ventures, Lifetime Ventures and Chile Ventures”